Psilocybin
4-Phosphoryloxy-N,N-dimethyltryptamine; a prodrug found in Psilocybe genus mushrooms. Dephosphorylated in vivo to psilocin (the active form) by alkaline phosphatase. Active at 1-4 mg. Rescheduled for therapeutic use in Australia from July 2023.